📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Orbis Biosciences

1.1 - Company Overview

Orbis Biosciences Logo

Orbis Biosciences

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of scalable materials encapsulation solutions, enabling precise control of particle size, encapsulation material, shell thickness, and porosity for applications in drug formulations, agricultural compounds, and novel food processing techniques.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Orbis Biosciences

Psycheceutical Logo

Psycheceutical

HQ: United States Website
  • Description: Provider of patented delivery technologies for safe, bioavailable psychedelic pharmaceutical medicines, featuring NeuroDirect non-systemic topical delivery of neuro-active compounds directly into nerve tissue for immediate, sustained effects with dosage control and minimized systemic side effects, and a NeuroDirect ketamine topical in Phase I for PTSD targeting nerve endings without hallucinogenic effects.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Psycheceutical company profile →
Alvotech Logo

Alvotech

HQ: Iceland Website
  • Description: Provider of fully integrated biosimilar development and manufacturing, including monoclonal antibodies for immunology, oncology, and ophthalmology. Offers R&D and clinical services and worldwide commercial partnerships to expand access to biologic medicines. Employs single-use technology and Iceland’s renewable energy. Portfolio includes AVT02 (adalimumab) and AVT04 (ustekinumab), approved across multiple regions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alvotech company profile →
Aurex Labs Logo

Aurex Labs

HQ: United States Website
  • Description: Provider of fully integrated pharmaceutical development and manufacturing services, including high-quality clinical supplies, tablets, and soft gelatin capsules. Maintains capabilities for manufacturing various dosage forms and quality control.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aurex Labs company profile →
Chiva Pharmaceuticals Logo

Chiva Pharmaceuticals

HQ: United States Website
  • Description: Provider of global pharmaceutical solutions focused on bringing the best standard of care to the Chinese market and making drugs developed in China available worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Chiva Pharmaceuticals company profile →
Genkyotex Logo

Genkyotex

HQ: Switzerland Website
  • Description: Provider of innovative drugs and platform technology that block NOX enzymes producing oxygen radicals to treat oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy. Offerings include setanaxib and a NOX inhibitor platform.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genkyotex company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Orbis Biosciences

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Orbis Biosciences

2.2 - Growth funds investing in similar companies to Orbis Biosciences

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Orbis Biosciences

4.2 - Public trading comparable groups for Orbis Biosciences

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Orbis Biosciences

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Orbis Biosciences

What does Orbis Biosciences do?

Orbis Biosciences is a provider of scalable materials encapsulation solutions, enabling precise control of particle size, encapsulation material, shell thickness, and porosity for applications in drug formulations, agricultural compounds, and novel food processing techniques.

Who are Orbis Biosciences's competitors?

Orbis Biosciences's competitors and similar companies include Psycheceutical, Alvotech, Aurex Labs, Chiva Pharmaceuticals, and Genkyotex.

Where is Orbis Biosciences headquartered?

Orbis Biosciences is headquartered in United States.

How many employees does Orbis Biosciences have?

Orbis Biosciences has 1,000 employees 🔒.

When was Orbis Biosciences founded?

Orbis Biosciences was founded in 2010 🔒.

What sector and industry vertical is Orbis Biosciences in?

Orbis Biosciences is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Orbis Biosciences

Who are the top strategic acquirers in Orbis Biosciences's sector and industry

Top strategic M&A buyers and acquirers in Orbis Biosciences's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Orbis Biosciences?

Top strategic M&A buyers groups and sectors for Orbis Biosciences include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Orbis Biosciences's sector and industry vertical

Which are the top PE firms investing in Orbis Biosciences's sector and industry vertical?

Top PE firms investing in Orbis Biosciences's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Orbis Biosciences's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Orbis Biosciences's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Orbis Biosciences's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Orbis Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Orbis Biosciences's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Orbis Biosciences?

The key public trading comparables and valuation benchmarks for Orbis Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Orbis Biosciences for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Orbis Biosciences with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Orbis Biosciences's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Orbis Biosciences with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Orbis Biosciences's' sector and industry vertical?

Access recent funding rounds and capital raises in Orbis Biosciences's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Orbis Biosciences